Centene Co. (NYSE:CNC – Free Report) – Equities research analysts at Zacks Research increased their FY2026 EPS estimates for shares of Centene in a report issued on Wednesday, June 26th. Zacks Research analyst K. Dey now forecasts that the company will post earnings of $8.49 per share for the year, up from their prior forecast of $8.47. The consensus estimate for Centene’s current full-year earnings is $6.82 per share.
Centene (NYSE:CNC – Get Free Report) last released its earnings results on Friday, April 26th. The company reported $2.26 earnings per share for the quarter, topping analysts’ consensus estimates of $2.09 by $0.17. The company had revenue of $40.41 billion during the quarter, compared to the consensus estimate of $36.43 billion. Centene had a return on equity of 14.19% and a net margin of 1.76%. During the same quarter in the previous year, the company posted $2.11 EPS. Centene’s quarterly revenue was up 3.9% compared to the same quarter last year.
Get Our Latest Analysis on Centene
Centene Stock Down 0.5 %
CNC opened at $67.36 on Friday. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.66. The business’s 50-day moving average price is $72.76 and its 200-day moving average price is $74.94. The company has a market cap of $35.95 billion, a P/E ratio of 13.39, a P/E/G ratio of 0.87 and a beta of 0.47. Centene has a 12 month low of $60.83 and a 12 month high of $81.42.
Institutional Investors Weigh In On Centene
Several institutional investors and hedge funds have recently made changes to their positions in CNC. Rise Advisors LLC bought a new stake in shares of Centene in the 1st quarter worth $25,000. Turtle Creek Wealth Advisors LLC purchased a new stake in shares of Centene during the fourth quarter valued at $25,000. Operose Advisors LLC purchased a new position in Centene in the 3rd quarter worth about $25,000. Riggs Asset Managment Co. Inc. bought a new position in Centene during the 4th quarter valued at about $32,000. Finally, Headinvest LLC bought a new stake in shares of Centene in the third quarter worth approximately $35,000. Institutional investors own 93.63% of the company’s stock.
Insider Activity at Centene
In other Centene news, President Kenneth J. Fasola sold 8,000 shares of the firm’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $77.62, for a total transaction of $620,960.00. Following the completion of the transaction, the president now owns 300,357 shares of the company’s stock, valued at $23,313,710.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, President Kenneth J. Fasola sold 8,000 shares of the stock in a transaction on Monday, May 13th. The stock was sold at an average price of $77.62, for a total value of $620,960.00. Following the sale, the president now directly owns 300,357 shares of the company’s stock, valued at $23,313,710.34. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Christopher J. Coughlin sold 878 shares of Centene stock in a transaction dated Tuesday, May 14th. The stock was sold at an average price of $76.75, for a total value of $67,386.50. Following the completion of the transaction, the director now directly owns 25,504 shares of the company’s stock, valued at approximately $1,957,432. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by corporate insiders.
Centene Company Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
See Also
- Five stocks we like better than Centene
- Stock Sentiment Analysis: How it Works
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- The 3 Best Retail Stocks to Shop for in August
- Progress Software Stock Back in the Green After Beating Forecasts
- Insider Trades May Not Tell You What You Think
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.